Muc4/sialomucin complex in the mammary gland and breast cancer

被引:76
作者
Carraway, KL
Price-Schiavi, SA
Komatsu, M
Jepson, S
Perez, A
Carraway, CAC
机构
[1] Univ Miami, Sch Med, Dept Cell Biol & Anat R 124, Miami, FL 33101 USA
[2] Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA
关键词
mucin; ErbB2; regulations; antiadhesion; epithelia; breast carcinoma;
D O I
10.1023/A:1011327708973
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MUC4 is a one of the membrane mucins of the mucin gene (MUC) family, characterized by mucin tandem repeat domains and a transmembrane domain which associates it with the cell plasma membrane. Although MUC4 is encoded by a single gene, it is produced by epithelial cells as a heterodimer through a proteolytic cleavage mechanism. This heterodimer is found in both membrane and soluble forms associated with epithelia. Functionally, MUC4 is proposed to provide a protective mechanism for vulnerable epithelia, such as those of the airway, eye, female reproductive tract and mammary gland. The protective mechanism(s) may be highjacked by some carcinomas, such as those of the breast, to increase tumor progression. Two mechanisms are proposed to contribute to the MUC4 functions. First, MUC4 acts as an anti-adhesive or anti-recognition barrier at epithelial or tumor cell surfaces. Second, MUC4 can bind the receptor tyrosine kinase ErbB2 and alter its cellular signaling. Expression of MUC4 in mammary gland is repressed by posttranscriptional mechanisms involving basement membrane and TGF-beta, which are relieved during pregnancy to permit secretion of MUC4 into milk. These mechanisms are also abrogated in some breast cancers, providing a scenario for promotion of tumor progression. These observations imply important functions for MUC4 in both normal mammary function and in breast cancer.
引用
收藏
页码:323 / 337
页数:15
相关论文
共 95 条
[1]  
ARANGO ME, UNPUB PRODUCTION MUC
[2]   ALTERED EXPRESSION OF MUC2, MUC4, AND MUC5 MUCIN GENES IN PANCREAS TISSUES AND CANCER CELL-LINES [J].
BALAGUE, C ;
GAMBUS, G ;
CARRATO, C ;
PORCHET, N ;
AUBERT, JP ;
KIM, YS ;
REAL, FX .
GASTROENTEROLOGY, 1994, 106 (04) :1054-1061
[3]   IN-SITU HYBRIDIZATION SHOWS DISTINCT PATTERNS OF MUCIN GENE-EXPRESSION IN NORMAL, BENIGN, AND MALIGNANT PANCREAS TISSUES [J].
BALAGUE, C ;
AUDIE, JP ;
PORCHET, N ;
REAL, FX .
GASTROENTEROLOGY, 1995, 109 (03) :953-964
[4]  
BOBEK LA, 1993, J BIOL CHEM, V268, P20563
[5]   O-linked glycosylation in the mammary gland: Changes that occur during malignancy [J].
Burchell, JM ;
Mungul, A ;
Taylor-Papadimitriou, J .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2001, 6 (03) :355-364
[6]   IN HIV-INFECTED INDIVIDUALS WHO DESIRE COMBINATION ANTIVIRAL THERAPY, ZIDOVUDINE PLUS ZALCITABINE IS PREFERRED TO ZIDOVUDINE PLUS DIDANOSINE [J].
CARR, A ;
COOPER, DA .
REVIEWS IN MEDICAL VIROLOGY, 1994, 4 (01) :5-8
[7]   Association of the Ras to mitogen-activated protein kinase signal transduction pathway with microfilaments -: Evidence for a p185neu-containing cell surface signal transduction particle linking the mitogenic pathway to a membrane-microfilament association site [J].
Carraway, CAC ;
Carvajal, ME ;
Carraway, KL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (36) :25659-25667
[8]  
CARRAWAY KL, 1992, J CELL SCI, V103, P299
[9]   An intramembrane modulator of the ErbB2 receptor tyrosine kinase that potentiates neuregulin signaling [J].
Carraway, KL ;
Rossi, EA ;
Komatsu, M ;
Price-Schiavi, SA ;
Huang, DM ;
Guy, PM ;
Carvajal, ME ;
Fregien, N ;
Carraway, CAC ;
Carraway, KL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (09) :5263-5266
[10]   MUCIN STRUCTURE AND FUNCTION - INSIGHTS FROM MOLECULAR-BIOLOGY [J].
CARRAWAY, KL ;
FREGIEN, N .
TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY, 1995, 7 (33) :31-44